Hartlon Vascular, Inc.
PrivateLast Round
Grant
Dec 2, 2024
Total Funding Raised
$100,000
Company Overview
Hartlon Vascular, Inc. is a medical device company that develops drug-eluting, bioresorbable vascular scaffolds for the treatment of peripheral artery disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hartlon Vascular, Inc. Comparables
Compare Hartlon Vascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Vascular Inc. | 87% | |
| REVA Medical | 81% | |
| Elixir Medical Corporation | 80% |
Hartlon Vascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2024 | ||||
| Grant | Jul 21, 2022 | ||||
| Accelerator | Feb 9, 2021 |
Hartlon Vascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delaware Division of Small Business | Grant |
| The Innovation Space | Grant, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2024
Received grant funding from The Innovation Space.
- Jul 21, 2022
$100K grant received from Delaware Division of Small Business.
Hartlon Vascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hartlon Vascular, Inc.'s valuation, stock price, and market status.
Is Hartlon Vascular, Inc. a public or private company?
Hartlon Vascular, Inc. is a private company.
What is the current stock price of Hartlon Vascular, Inc.?
Hartlon Vascular, Inc. is a private company with no public stock price. Caplight tracks Hartlon Vascular, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Hartlon Vascular, Inc. worth (valuation)?
Valuation information for Hartlon Vascular, Inc. is not publicly available.
Can I buy Hartlon Vascular, Inc. stock?
Hartlon Vascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hartlon Vascular, Inc.'s last funding round?
Hartlon Vascular, Inc.'s most recent funding round was Grant on December 2, 2024.
Who are the main investors in Hartlon Vascular, Inc.?
Key investors in Hartlon Vascular, Inc. include Delaware Division of Small Business, The Innovation Space.
Will Hartlon Vascular, Inc. IPO soon?
No public IPO plans have been announced for Hartlon Vascular, Inc..
How can I track Hartlon Vascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hartlon Vascular, Inc.'s secondary market activity and sign up for updates.